Latest statistics and disclosures from Ulys's latest quarterly 13F-HR filing:

  • Ulys was a net seller of stock by $0.

Companies in the Ulys portfolio as of September 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Lexicon Pharmaceuticals 100.00 4.32M 12.29

Past 13F-HR SEC Filings by Ulys

View All Filings